secwatch.observer — SEC 8-K summary
======================================

Issuer:     Akili, Inc. (—)
CIK:        0001850266
Form:       8-K
Filed at:   2023-12-20T23:59:59+00:00
Accession:  0001193125-23-300008
Event type: regulatory
Sentiment:  negative
Materiality: 0.50
Item codes: 3.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director resignation causes Akili to lose board independence and Nasdaq compliance
--------------------------------------------------------------------------------

- Kenneth Ehlert resigned from board and audit committee effective Dec 19, 2023; not due to any disagreement.
- Board now has 3 independent and 3 non-independent directors, violating Nasdaq majority independence requirement.
- Audit Committee reduced to 2 members, violating Nasdaq requirement for at least 3 members.
- Nasdaq granted cure period until earlier of next annual meeting or Dec 19, 2024; if annual meeting before June 17, 2024, compliance by June 17, 2024.
- Company is reviewing options; no immediate effect on listing; common stock continues trading under AKLI.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850266/000119312523300008/0001193125-23-300008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850266/000119312523300008/d676863d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-300008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer